immunoglubulin M Archives

What’s In That Hand Sanitiser?

4 April 2022

Learn From Parabens. Over recent years, there has been much greater awareness of the use of parabens in cosmetics and toiletries. Many products have become ‘parabens-free’ as increased research has shown the effects of parabens 𝘪𝘯 𝘷𝘪𝘷𝘰. As xenoestrogen, parabens molecularly mimic naturally-occurring estrogen. They function as selective estrogen receptor modulators, becoming synthetic ligands that […]

Antiphospholipid Antibodies And COVID-19 Vaccines.

25 August 2021

Background. As early as October 2020 – over ten months ago – we explained why a vaccine was not needed and would not be effective. That’s a vaccine using its correct medical definition, i.e. a prophylactic treatment providing long-term or lifetime protection. All of the four main treatment candidates being injected – Vaxzevria; BNT126b2; mRNA-1273 […]

Why Is Nitric Oxide’s Key Role Ignored?

28 July 2021

Role In The Innate Immune Response. It is a year since we first identified the significance of vitamin D in respect of SARS-CoV-2. Through the vitamin D pathways it can both prevent viral infection and attenuate disease progression and severity. Yet the role of vitamin D-modulated nitric oxide remains largely ignored and dismissed by the NHS as […]

Questions For Those Offering You A ‘Vaccine’.

4 May 2021

Beware ‘Excited’ Non-Healthcare Workers. As another cohort is now to be offered the antivirals (they are not vaccines), it is apposite to set out some questions to ask those who are falling over themselves to vaccinate you. There is an irony in the fact that reception staff at GPs’ surgeries who are usually obdurate and […]

These ‘Vaccines’ Become More Dangerous By The Day.

15 April 2021

Treatments Targeting The S Protein Were Already Ineffective. We have been vehement critics of the miracle ‘wonderdrug’ antivirals (they are not vaccines) rushed onto the market in recent months. In October 2020, we first set out the difference between vaccines and antivirals and highlighted the risks in RNA/mRNA vaccine candidates: these fall into the category […]

The ‘Third Wave’ That Has Been Here All Along.

24 March 2021

B1.1.7 v B1.1.28 v B1.351. As we have previously explained, SARS-CoV-2 neither thinks nor acts geographically. Yet the misleading designation of SARS-CoV-2 variants on a geographical basis continues to dominate media coverage and government obsession, with the putative ‘third wave’ being down to either the Brazilian variant or the UK variant dependent upon whether you […]

IgA – Faster, Stronger and More Effective.

11 March 2021

The Star Player On Your Team. Following seroconversion, immumoglobulin A (IgA) istoype is the most frequently created antibody in the immune system. This is principally because it dominates the upper respiratory tract, which is usually the first point of contact between pathogen and human. Therefore, it is needed more frequently than the other isotypes. As […]

Exoribonuclease – Your Starter For Ten Mr Prime Minister.

30 December 2020

Q1. How can a virus containing an exoribonuclease mutate in the way you are saying? Coronaviruses possess an exoribonuclease within nonstructural protein 14 (nsp14-ExoN). This functions as a proofreader during viral transcription and encoding, ensuring high fidelity replication. This minimises the potential for mutation, as shown by the fact that sarbecovirus/lineage B betacoronaviruses with their […]

Having A Common Cold Is As Good As A Vaccine.

15 December 2020

Learn From The Common Cold. Pretty much everybody now knows that four coronaviruses cause the common cold: duvinacovirus alphacoronavirus HCoV-229E & setracovirus alphacoronavirus HCoV-NL63 and embecovirus or lineage A betacoronaviruses HCoV-HKU1 and HCoV-OC43. That’s the common cold that you can catch over & over and which is dealt with by the innate immune system only, […]

Déjà vu – memory T cells have seen SARS-CoV-2 before.

23 November 2020

Newly-Discovered Is Not New. In early September we first highlighted the incorrect designation of SARS-CoV-2 as a ‘novel’ or ‘new’ coronavirus when it should have been designated ‘newly-discovered’. There is a subtle but fundamental difference: something that is new did not previously exist whereas something that is newly-discovered already existed but not been discovered yet. […]